Prevalence of wild ‐type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo‐VIP‐HF study
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - March 5, 2024 Category: Cardiology Authors: Alwin Tubben,
Hendrea S.A. Tingen,
Niek H.J. Prakken,
Vanessa P.M. van Empel,
Thomas M. Gorter,
Laura M.G. Meems,
Olivier C. Manintveld,
Michiel Rienstra,
Robert G. Tieleman,
Andor W.J.M. Glaudemans,
Dirk J. van Veldhuisen,
Riemer H.J.A. Slart, Tags: Research Letter Source Type: research
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR ‐Preserved analysis
ConclusionIn EMPEROR-Preserved, LRTI was frequent and associated with a poor prognosis. Empagliflozin was associated with a reduced risk of LRTI compared to placebo. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - March 5, 2024 Category: Cardiology Authors: Jo ão Pedro Ferreira,
Faiez Zannad,
Milton Packer,
Gerasimos Filippatos,
Stuart J. Pocock,
Francisco Vasques‐Nóvoa,
Michael Böhm,
Javed Butler,
Stefan Anker Tags: Research Article Source Type: research
Association of diabetes ‐specific heart failure risk score with presence of subclinical cardiomyopathy among individuals with diabetes: A prospective study
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - March 5, 2024 Category: Cardiology Authors: Zainali S. Chunawala,
Neil Keshvani,
Matthew W. Segar,
Kershaw V. Patel,
Muhammad Shariq Usman,
Vinayak Subramanian,
Viraj Raygor,
Alvin Chandra,
Muhammad Shahzeb Khan,
Ambarish Pandey Tags: Research Letter Source Type: research
Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme
ConclusionAcross the range of EF in patients with chronic HF enrolled in the EMPEROR trials, the majority of whom did not have clinical evidence of congestion, CA-125 concentrations were not significantly associated with congestive signs or symptoms. CA-125 concentrations may predict HF hospitalization/CV death in patients with HFrEF, but not those with HFpEF.Clinical Trial Registration: EMPEROR-Reduced (NCT03057977), EMPEROR-Preserved (NCT03057951). (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - March 5, 2024 Category: Cardiology Authors: Jo ão Pedro Ferreira,
Milton Packer,
Naveed Sattar,
Javed Butler,
Stuart J. Pocock,
Stefan D. Anker,
Sandra González Maldonado,
Marina Panova‐Noeva,
Mikhail Sumin,
Serge Masson,
Faiez Zannad,
James L. Januzzi Tags: Research Article Source Type: research
Apoptosis, a useful marker in the management of hot ‐phase cardiomyopathy?
ConclusionsApoptosis, rather than significant inflammation, was mostly prevalent in this case series of patients with ‘hot-phase’ presentation, especially in carriers of variants in cardiomyopathy-related genes. Detecting apoptosis on EMB might guide clinicians in performing genetic testing and in more tailored therapeutic choices in ‘hot-phase cardiomyopathy’. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - February 28, 2024 Category: Cardiology Authors: Giulia Bassetto,
Marco Merlo,
Matteo Dal Ferro,
Martina Setti,
Alessia Paldino,
Chiara Collesi,
Rebecca Artioli,
Francesco Loffredo,
Saverio D'Elia,
Paolo Golino,
Enrico Fabris,
Rossana Bussani,
Marco Metra,
Giuseppe Limongelli,
Gianfranco S Tags: Research Article Source Type: research
An exercise enigma: Unravelling the complexity of exercise intolerance in heart failure with preserved ejection fraction
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - February 28, 2024 Category: Cardiology Authors: Matthew W. Segar,
Ajith Nair,
Ambarish Pandey Tags: Invited Editorial Source Type: research
Right heart failure as a cause of pulmonary congestion in pulmonary arterial hypertension
ConclusionLung ultrasound commonly discloses pulmonary congestion in PAH. This finding is related to right ventricular to pulmonary artery uncoupling, and may tentatively be explained by increased central venous pressure impeding lymphatic outflow. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - February 27, 2024 Category: Cardiology Authors: Michele D'Alto,
Marco Di Maio,
Paola Argiento,
Emanuele Romeo,
Gaetano Rea,
Biagio Liccardo,
Carmen Del Giudice,
Andrea Vergara,
Eleonora Caiazza,
Gerardo Elia Del Vecchio,
Alessandro Di Vilio,
Luna Gargani,
Antonello D'Andrea,
Eduardo Bosson Tags: Research Article Source Type: research
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy
ConclusionIn DCM patients, the combination of early detected NSVT and unexplained syncope increases the risk of life-threatening arrhythmic outcomes and can aid the identification of carriers of malignant arrhythmogenic genotypes. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - February 26, 2024 Category: Cardiology Authors: Martina Setti,
Marco Merlo,
Marta Gigli,
Laura Munaretto,
Alessia Paldino,
Davide Stolfo,
Carola Pio Loco,
Kristen Medo,
Caterina Gregorio,
Antonio De Luca,
Sharon Graw,
Matteo Castrichini,
Antonio Cannat à,
Flavio Luciano Ribichini,
Matteo Tags: Research Article Source Type: research
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors
Cardiogenic shock is a primary cardiac disorder that results in both clinical and biochemical evidence of tissue hypoperfusion and can lead to multi-organ failure and death depending on its severity. Inadequate cardiac contractility or cardiac power secondary to acute myocardial infarction remains the most frequent cause of cardiogenic shock, although its contribution has declined over the past two decades, compared with other causes. Despite some advances in cardiogenic shock management, this clinical syndrome is still burdened by an extremely high mortality. Its management is based on immediate stabilization of haemodyna...
Source: European Journal of Heart Failure - February 24, 2024 Category: Cardiology Authors: Mauro Riccardi,
Matteo Pagnesi,
Ovidiu Chioncel,
Alexandre Mebazaa,
Gad Cotter,
Finn Gustafsson,
Daniela Tomasoni,
Nicola Latronico,
Marianna Adamo,
Marco Metra Tags: Review Article Source Type: research
New opportunity for targeting systemic inflammation in patients with heart failure through leucocyte immunomodulation
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - February 23, 2024 Category: Cardiology Authors: Bertram Pitt,
Sai Prasad N. Iyer,
H. David Humes Tags: Viewpoint Source Type: research
Use of natriuretic peptides and echocardiography for diagnosing heart failure
ConclusionsWe found low rates of echocardiography and NP testing in those with HF, with more of such testing performed amongst inpatient diagnoses. We also found increasing rates of inpatient HF diagnoses, indicating lost opportunities for earlier treatment initiation and better outcomes. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - February 21, 2024 Category: Cardiology Authors: Khawaja M. Talha,
James L. Januzzi Jr,
Tong Meng,
Stephen J. Greene,
Muthiah Vaduganathan,
Tijana K. Janicijevic,
Ani John,
Antoni Bayes ‐Genis,
Javed Butler Tags: Research Article Source Type: research
Reply to ‘Vasodilators in congestive heart failure: The perfect weapon aiming just off the target?’
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - February 21, 2024 Category: Cardiology Authors: Pierpaolo Pellicori,
G. Michael Felker,
John G.F. Cleland Tags: Letter to the Editor Source Type: research
Correction to ‘Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology’
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - February 21, 2024 Category: Cardiology Tags: Correction Source Type: research
Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left ‐sided valvular heart disease in Europe. Insights from the ESC‐EORP Valvular Heart Disease II survey
ConclusionIn this large international prospective survey among patients with severe left-sided VHD, moderate/severe TR was frequent in patients with mitral valve disease and was associated with a poorer outcome as TR grade increased. In patients with severe TR, compliance to guidelines for class I indications for concomitant TV surgery at the time of left-sided heart valve surgery was very good. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - February 20, 2024 Category: Cardiology Authors: Julien Dreyfus,
Monika Komar,
David Attias,
Michele De Bonis,
Frank Ruschitzka,
Bogdan A. Popescu,
C écile Laroche,
Christophe Tribouilloy,
Alexander Bogachev Prokophiev,
Vaida Mizariene,
Jeroen J. Bax,
Aldo Pietro Maggioni,
David Messika‐Z Tags: Research Article Source Type: research
Early left ventricular unloading via active transseptal left atrial venting in case of cardiogenic shock under veno ‐arterial extracorporeal membrane oxygenation: A meta‐analysis
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - February 20, 2024 Category: Cardiology Authors: Aurore Ughetto,
Safa Aouinti,
Nicolas Molinari,
Fran çois Roubille,
Clément Delmas Tags: Research Letter Source Type: research
